
    
      Single oral administrations of study drug in two periods separated by a washout period of 07
      days. Subjects will take their assigned study medication orally, together with 240 mL of
      ambient temperature water, at least 1 hour after start of the meal at their scheduled dosing
      time-point. Total duration of treatment of study drug will be of 58 hours comprising 10 hours
      prior drug administration until 48 hours post dose in each study period.

      Pharmacokinetic parameters include Rivaroxaban plasma concentrations at the given sampling
      times. In each period 16 blood samples for plasma Rivaroxaban concentrations will be taken on
      Day 2, Day 3 and Day 4 including 0.00 hour pre dose and post dose at 0.25, 0.5, 1.00, 1.50,
      2.00, 2.50, 3.00, 3.5, 4.00, 6.00, 8.00, 12.00, 24.00, 36.00 and 48.00 hours.
    
  